Go to:
Logótipo
Você está em: Start > Publications > View > Anti-Tumor Necrosis Factor-alpha-Induced Dermatological Complications in a Large Cohort of Inflammatory Bowel Disease Patients
Map of Premises
Principal
Publication

Anti-Tumor Necrosis Factor-alpha-Induced Dermatological Complications in a Large Cohort of Inflammatory Bowel Disease Patients

Title
Anti-Tumor Necrosis Factor-alpha-Induced Dermatological Complications in a Large Cohort of Inflammatory Bowel Disease Patients
Type
Article in International Scientific Journal
Year
2018
Authors
Andrade, P
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Lopes, S
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Gaspar, R
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Nunes, A
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Magina, S
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Macedo G
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Journal
Vol. 63
Pages: 746-754
ISSN: 0163-2116
Publisher: Springer Nature
Other information
Authenticus ID: P-00N-HW5
Abstract (EN): The broader use of anti-tumor necrosis factor (TNF) agents in inflammatory bowel disease (IBD) has been associated with a high rate of adverse reactions. Dermatological complications are among the most common adverse events. We assessed the incidence, risk factors, management, and outcome of anti-TNF-induced dermatological complications in a large cohort of IBD patients. This was an observational retrospective study at a single tertiary referral center. All consecutive adult IBD patients treated with anti-TNF agents between 2005 and 2015 were identified. Patients who developed at least one dermatological complication while on anti-TNF therapy were included. From the 732 patients treated with anti-TNF agents, 211 (29%) developed at least one dermatological complication: 52% women (mean age of 42 +/- 13 years), 85% with Crohn's disease, 67% were under infliximab. Median follow-up time under anti-TNF therapy was 53 (27-77) months. Dermatological complications recorded were: infections (13.5%), psoriasiform lesions (5.3%), injection/infusion reactions (3.8%), skin cancer (0.5%), and miscellaneous (5.6%). Overall, female gender (OR = 1.658, p = 0.029), smoking (OR = 2.021, p = 0.003), and treatment with an infliximab dose of 10 mg/kg (OR = 2.012, p = 0.007) were independent risk factors for dermatological complications in multivariable analysis. Female gender (OR = 3.63, p = 0.017), smoking (OR = 2.846, p = 0.041), and treatment with adalimumab (OR = 8.894, p < 0.001) were independently associated with development of psoriasiform lesions. Three (3%) patients with infectious complications and 12 (31%) patients with psoriasiform lesions discontinued anti-TNF therapy definitively. Dermatological manifestations occurred in almost one-third of our population. Infections were the most common complication, but anti-TNF-induced psoriasiform lesions were the most common cause for anti-TNF therapy definitive discontinuation.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 9
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

The Effect of Ischemia and Reperfusion on Enteric Glial Cells and Contractile Activity in the Ileum (2015)
Article in International Scientific Journal
Mendes, CE; Palombit, K; Vieira, C; Silva, I; Paulo Correia de Sá; Castelucci, P
Soluble selectins, sICAM, sVCAM, and angiogenic proteins in different activity groups of patients with inflammatory bowel disease (2004)
Article in International Scientific Journal
magro, f; araujo, f; pereira, p; meireles, e; diniz-ribeiro, m; velosom, ft
Multiple myeloma presenting with malabsorption (2007)
Article in International Scientific Journal
Cardoso, H; Sousa S Machado; Figueira, P; Vasconcelos V Teixeira; Tavarela T Veloso; Lopes, JM
Intestinal 5-hydroxytryptamine and mast cell infiltration in rat experimental colitis (2006)
Article in International Scientific Journal
Magro F; Sonia Fraga; Azevedo, I; soares-da-silva, p
Inflammatory Bowel Disease: A Patient's and Caregiver's Perspective (2009)
Article in International Scientific Journal
Magro F; Portela, F; Lago, P; Deus, J; Cotter, J; Cremers, I; vieira-coelho, ma; Peixe, P; Caldeira, P; Lopes, H; Goncalves, R; Reis, J; Cravo, M; Barros, L; Ministro, P; Tavares, ML; Duarte, A; Campos, M; Carvalho, L; Areia, M

See all (9)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Medicina Dentária da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-25 at 01:44:32 | Privacy Policy | Personal Data Protection Policy | Whistleblowing | Electronic Yellow Book